Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ravi

Showing results (231-240 of 263) with videos related to

Pageof 27
Sort By:
Bioorganic & Medicinal Chemistry|April 10, 2007
Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2Allan Wissner, Heidi L Fraser, Charles L Ingalls, et al.
Journal of Contaminant Hydrology|September 27, 2016
Effect of compositional heterogeneity on dissolution of non-ideal LNAPL mixturesM Vasudevan, C D Johnston, T P Bastow, et al.
Diabetes Research and Clinical Practice|October 29, 2017
A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetesPhilip Home, R Ravi Shankar, Ira Gantz, et al.
Journal of Clinical & Translational Endocrinology|February 22, 2019
Dyslipidemia: The untreated metabolic dysfunction in people with type 2 diabetes in Latin America. ARETAEUS study outcomesJuan José Gagliardino, Rosario Arechavaleta, Freddy Goldberg Eliaschewitz, et al.
Gastro Hep Advances|July 21, 2025
Risk Prediction in Patients With Metabolic Dysfunction-Associated Steatohepatitis Using Natural Language ProcessingJordan Guillot, Christopher Y K Williams, Shadera Azzam, et al.
Journal of Applied Microbiology|June 27, 2017
In vitro efficacy and in silico analysis of cefixime-ofloxacin combination for Salmonella Typhi from bloodstream infectionY D Bakthavatchalam, D T Kumar, I A Tayubi, et al.
Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India|August 9, 2021
Risk Based Decision Algorithms for Management of COVID-19 Associated Rhino-orbital MucormycosisNeeti Kapre Gupta, Madan Kapre, Harshkaran Gupta, et al.
International Journal of Clinical Practice|May 26, 2017
Direct medical costs of severe hypoglycaemic events in patients with type 2 diabetes in England: A retrospective database studyTim Holbrook, Yuexin Tang, Romita Das, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 31, 2015
p16 Expression as a Surrogate Marker for HPV Infection in Esophageal Squamous Cell Carcinoma can Predict Response to Neo-Adjuvant ChemotherapyRajeev Kumar, Sankar Kumar Ghosh, Akalesh Kumar Verma, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 1, 2004
A validated chiral LC method for the enantioselective analysis of Levetiracetam and its enantiomer R-alpha-ethyl-2-oxo-pyrrolidine acetamide on amylose-based stationary phaseB M Rao, R Ravi, B Shyam Sundar Reddy, et al.
Pageof 27

Showing results (231-240 of 263) with videos related to

Sort By:
Pageof 27
Bioorganic & Medicinal Chemistry|April 10, 2007
Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2Allan Wissner, Heidi L Fraser, Charles L Ingalls, et al.
Journal of Contaminant Hydrology|September 27, 2016
Effect of compositional heterogeneity on dissolution of non-ideal LNAPL mixturesM Vasudevan, C D Johnston, T P Bastow, et al.
Diabetes Research and Clinical Practice|October 29, 2017
A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetesPhilip Home, R Ravi Shankar, Ira Gantz, et al.
Journal of Clinical & Translational Endocrinology|February 22, 2019
Dyslipidemia: The untreated metabolic dysfunction in people with type 2 diabetes in Latin America. ARETAEUS study outcomesJuan José Gagliardino, Rosario Arechavaleta, Freddy Goldberg Eliaschewitz, et al.
Gastro Hep Advances|July 21, 2025
Risk Prediction in Patients With Metabolic Dysfunction-Associated Steatohepatitis Using Natural Language ProcessingJordan Guillot, Christopher Y K Williams, Shadera Azzam, et al.
Journal of Applied Microbiology|June 27, 2017
In vitro efficacy and in silico analysis of cefixime-ofloxacin combination for Salmonella Typhi from bloodstream infectionY D Bakthavatchalam, D T Kumar, I A Tayubi, et al.
Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India|August 9, 2021
Risk Based Decision Algorithms for Management of COVID-19 Associated Rhino-orbital MucormycosisNeeti Kapre Gupta, Madan Kapre, Harshkaran Gupta, et al.
International Journal of Clinical Practice|May 26, 2017
Direct medical costs of severe hypoglycaemic events in patients with type 2 diabetes in England: A retrospective database studyTim Holbrook, Yuexin Tang, Romita Das, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 31, 2015
p16 Expression as a Surrogate Marker for HPV Infection in Esophageal Squamous Cell Carcinoma can Predict Response to Neo-Adjuvant ChemotherapyRajeev Kumar, Sankar Kumar Ghosh, Akalesh Kumar Verma, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 1, 2004
A validated chiral LC method for the enantioselective analysis of Levetiracetam and its enantiomer R-alpha-ethyl-2-oxo-pyrrolidine acetamide on amylose-based stationary phaseB M Rao, R Ravi, B Shyam Sundar Reddy, et al.
Pageof 27